Literature DB >> 1705998

Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1.

V Zachar1, B Spire, I Hirsch, J C Chermann, P Ebbesen.   

Abstract

We investigated the nature of interaction of the malignantly transformed cell lines of trophoblast origin BeWo, JAR, and JEG-3 with three different human immunodeficiency virus type 1 (HIV-1) isolates (RF, 3B, and NDK). After inoculation with cell-free virus, the persistence of infection was determined for 1 month by monitoring the presence of viral DNA in the cells by the polymerase chain reaction (PCR). Furthermore, the infectious virus in the culture supernatant was assayed with CEM-SS cells, and attempts to rescue the virus by cocultivation with CEM-SS cells were made. Appraised on the basis of the relative amount of viral DNA and the frequency of positive cocultivation. JEG-3 was the most permissive and BeWo was the least permissive cell line. However, when the cells were transfected with two biologically active molecular clones of HIV-1, the BRU and NDK isolates, all three cell lines turned out to support the production of mature virus progeny to the same extent. The abundance of viral DNA sequences in the infected cells varied with the isolate, showing an overall decline from RF to NDK. The amount of viral DNA in the cells and its expression decreased during the period of observation; this decrease was mirrored in an erosion of the virus recovery rate at cocultivation from 71% recovery on day 8 to failure of isolation on day 32. None of the cell lines expressed detectable amounts of cell surface CD4 molecules when assayed by flow microfluorometry and direct radioimmunoassay. Northern (RNA) blot hybridization analysis of both the total RNA and the mRNA did not reveal any CD4-specific message: nonetheless, by using the PCR, sequences specifically related to the CD4 gene were uncovered. The data demonstrate that the trophoblast-derived cell lines are susceptible to infection with HIV and that they support transient viral replication in the initial phases of infection. However, the latent form of infection may persist over a period of several weeks.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705998      PMCID: PMC240075     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

2.  Oligonucleotide probes for the screening of recombinant DNA libraries.

Authors:  R B Wallace; C G Miyada
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Vertical transmission of HIV in 15-week fetus.

Authors:  S Sprecher; G Soumenkoff; F Puissant; M Degueldre
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

4.  LAV/HTLV-III in 20-week fetus.

Authors:  E Jovaisas; M A Koch; A Schäfer; M Stauber; D Löwenthal
Journal:  Lancet       Date:  1985-11-16       Impact factor: 79.321

5.  Differences among human immunodeficiency virus strains in their capacities to induce cytolysis or persistent infection of a lymphoblastoid cell line immortalized by Epstein-Barr virus.

Authors:  K Dahl; K Martin; G Miller
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

6.  HIV-1 infection of first-trimester and term human placental tissue: a possible mode of maternal-fetal transmission.

Authors:  W Maury; B J Potts; A B Rabson
Journal:  J Infect Dis       Date:  1989-10       Impact factor: 5.226

7.  Infection of human fetal dorsal root ganglion glial cells with human immunodeficiency virus type 1 involves an entry mechanism independent of the CD4 T4A epitope.

Authors:  C Kunsch; H T Hartle; B Wigdahl
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Epstein-Barr virus-positive and -negative B-cell lines can be infected with human immunodeficiency virus types 1 and 2.

Authors:  J E Monroe; A Calender; C Mulder
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

9.  Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions.

Authors:  A D Hoffman; B Banapour; J A Levy
Journal:  Virology       Date:  1985-12       Impact factor: 3.616

10.  Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes.

Authors:  Q J Sattentau; J Arthos; K Deen; N Hanna; D Healey; P C Beverley; R Sweet; A Truneh
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  14 in total

Review 1.  Heterogeneous pathways of maternal-fetal transmission of human viruses (review).

Authors:  A Saleh Younes; Márta Csire; Beatrix Kapusinszky; Katalin Szomor; Mária Takács; György Berencsi
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

2.  Efficient in vitro inhibition of HIV-1 gag reverse transcription by peptide nucleic acid (PNA) at minimal ratios of PNA/RNA.

Authors:  U Koppelhus; V Zachar; P E Nielsen; X Liu; J Eugen-Olsen; P Ebbesen
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

3.  Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection.

Authors:  S Lagaye; M Derrien; E Menu; C Coïto; E Tresoldi; P Mauclère; G Scarlatti; G Chaouat; F Barré-Sinoussi; M Bomsel
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Human trophoblast cells express CD4 and are permissive for productive infection with HIV-1.

Authors:  F J David; B Autran; H C Tran; E Menu; M Raphael; P Debre; B L Hsi; T G Wegman; F Barre-Sinoussi; G Chaouat
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

5.  Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract.

Authors:  A L Howell; R D Edkins; S E Rier; G R Yeaman; J E Stern; M W Fanger; C R Wira
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Placental cytokine and chemokine production in HIV-1-infected women: trophoblast cells show a different pattern compared to cells from HIV-negative women.

Authors:  M Moussa; P Roques; N Fievet; E Menu; J G Maldonado-Estrada; J Brunerie; R Frydman; X Fritel; F Herve; G Chaouat
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

7.  HIV-1 co-receptor expression on trophoblastic cells from early placentas and permissivity to infection by several HIV-1 primary isolates.

Authors:  B Mognetti; M Moussa; J Croitoru; E Menu; D Dormont; P Roques; G Chaouat
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

Review 8.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

Review 9.  Gene targeting in primary human trophoblasts.

Authors:  F J Rosario; Y Sadovsky; T Jansson
Journal:  Placenta       Date:  2012-07-23       Impact factor: 3.481

10.  Productive infection of a cervical epithelial cell line with human immunodeficiency virus: implications for sexual transmission.

Authors:  X Tan; R Pearce-Pratt; D M Phillips
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.